Les Laboratoires Servier: Pharmaceuticals and Healthcare Company Profile & SWOT ReportiCD ResearchFebruary 6, 2012 20 Pages - SKU: ICDR6793689 |
| Synopsis ICD Research's Les Laboratoires Servier: Pharmaceuticals and Healthcare Company Profile & SWOT Report contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services. Summary ICD Research's Les Laboratoires Servier: Pharmaceuticals and Healthcare Company Profile & SWOT Report is a crucial resource for industry executives and anyone looking to access key information about Les Laboratoires Servier. ICD Research's Les Laboratoires Servier: Pharmaceuticals and Healthcare Company Profile & SWOT Report report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope
Les Laboratoires Servier (Servier) is a leading independent pharmaceutical company in France and second French pharmaceutical company in the world. The company researches, develops, manufactures and markets drugs for the treatment of cardiovascular, asthenia, oncologic, endocrine, diabetes, and venous diseases, among others. Key products of the company include coversyl, coveram, hyperium, preterax, procoralan, valdoxan, duxil, diamicron mr, muphoran, arcalion, locabiotal, protelos, and daflon 500, among others. It has ICTRs (International Centers for Therapeutic Research) located in 19 countries across Asia-Pacific, Europe, South America and Canada. Also, the company has presence in 140 countries across the world. Servier is headquartered in Neuilly Sur Seine, France. |
Related Markets
Pharmaceuticals Company Reports
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012
- Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
- Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
- Partnerships, Licensing, Investments and M&A Deals and Trends for March 2012 in Pharmaceuticals
- Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

